| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $29,0900 | +5,09% | $1,74B | $212,15K | |
SGRY Surgery Partners, Inc. Common Stock | $13,6170 | +0,79% | $1,74B | $582,82K | |
GAB The Gabelli Equity Trust Inc. | $5,5750 | -0,62% | $1,74B | $889,71K | |
HURN Huron Consulting Group Inc. | $107,08 | +2,17% | $1,74B | $48,48K | |
ENVX Enovix Corporation Common Stock | $8,4130 | +2,22% | $1,74B | $4,02M | |
PAYO Payoneer Global Inc. Common Stock | $5,1150 | +0,49% | $1,74B | $1,80M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9380 | +0,19% | $1,73B | $135,10K | |
STGW Stagwell Inc. Class A Common Stock | $6,6250 | +0,53% | $1,73B | $443,08K | |
CASH Pathward Financial, Inc. Common Stock | $78,6700 | +1,20% | $1,73B | $88,07K | |
SNDX Syndax Pharmaceuticals, Inc. | $17,7850 | -3,03% | $1,73B | $5,05M | |
STRA Strategic Education, Inc. Common Stock | $80,8900 | +2,33% | $1,73B | $100,62K | |
CAPR Capricor Therapeutics Inc | $28,0700 | +1,56% | $1,73B | $266,77K | |
AAPG Ascentage Pharma Group International American Depository Shares | $18,4200 | +3,08% | $1,73B | $1,75K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $9,1050 | +11,17% | $1,73B | $5,25M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $27,3250 | +9,34% | $1,73B | $320,96K | |
